Eventide Asset Management Upped Achillion Pharmaceuticals In (ACHN) Holding; Atika Capital Management Trimmed Centene Del (CNC) Holding By $1.90 Million

November 14, 2017 - By Winifred Garcia

Atika Capital Management Llc decreased Centene Corp Del (CNC) stake by 44.44% reported in 2017Q2 SEC filing. Atika Capital Management Llc sold 24,000 shares as Centene Corp Del (CNC)’s stock rose 11.03%. The Atika Capital Management Llc holds 30,000 shares with $2.40M value, down from 54,000 last quarter. Centene Corp Del now has $16.07B valuation. The stock declined 1.28% or $1.21 reaching $93.15 per share. About 456,994 shares traded. Centene Corp (NYSE:CNC) has risen 32.56% since November 14, 2016 and is uptrending. It has outperformed by 15.86% the S&P500.

Eventide Asset Management Llc increased Achillion Pharmaceuticals In (ACHN) stake by 41.67% reported in 2017Q2 SEC filing. Eventide Asset Management Llc acquired 250,000 shares as Achillion Pharmaceuticals In (ACHN)’s stock 0.00%. The Eventide Asset Management Llc holds 850,000 shares with $3.90M value, up from 600,000 last quarter. Achillion Pharmaceuticals In now has $500.90 million valuation. The stock declined 4.94% or $0.19 reaching $3.66 on the news. About 704,757 shares traded. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) has declined 47.61% since November 14, 2016 and is downtrending. It has underperformed by 64.31% the S&P500.

Atika Capital Management Llc increased Medicines Co (NASDAQ:MDCO) stake by 114,000 shares to 190,000 valued at $7.22M in 2017Q2. It also upped Netflix Inc (NASDAQ:NFLX) stake by 5,000 shares and now owns 41,000 shares. Liberty Media Corp Delaware was raised too.

Since June 2, 2017, it had 0 buys, and 3 selling transactions for $793,784 activity. The insider BROOKS MARK J sold $163,004. GEPHARDT Richard A also sold $336,603 worth of Centene Corp (NYSE:CNC) on Monday, June 12. 3,900 shares valued at $294,177 were sold by DITMORE ROBERT K on Friday, June 2.

Among 19 analysts covering Centene Corporation (NYSE:CNC), 14 have Buy rating, 1 Sell and 4 Hold. Therefore 74% are positive. Centene Corporation had 49 analyst reports since July 22, 2015 according to SRatingsIntel. Cantor Fitzgerald maintained it with “Buy” rating and $107.0 target in Tuesday, October 24 report. Citigroup initiated the shares of CNC in report on Friday, October 2 with “Buy” rating. Piper Jaffray initiated the shares of CNC in report on Wednesday, January 4 with “Overweight” rating. Barclays Capital maintained it with “Equal-Weight” rating and $72 target in Wednesday, January 6 report. As per Monday, June 20, the company rating was upgraded by Barclays Capital. UBS maintained the stock with “Buy” rating in Wednesday, July 26 report. The company was initiated on Wednesday, December 21 by JP Morgan. On Thursday, June 16 the stock rating was initiated by Bernstein with “Market Perform”. The company was initiated on Monday, April 25 by Cowen & Co. The stock of Centene Corp (NYSE:CNC) has “Neutral” rating given on Tuesday, December 13 by Goldman Sachs.

Investors sentiment decreased to 1.21 in 2017 Q2. Its down 0.03, from 1.24 in 2017Q1. It dropped, as 43 investors sold CNC shares while 171 reduced holdings. 93 funds opened positions while 165 raised stakes. 151.16 million shares or 0.06% less from 151.25 million shares in 2017Q1 were reported. C Gp A S reported 0.25% in Centene Corp (NYSE:CNC). Epoch Prtn invested 0.07% of its portfolio in Centene Corp (NYSE:CNC). Hirtle Callaghan holds 144 shares. Tdam Usa invested 0.07% in Centene Corp (NYSE:CNC). Loomis Sayles & Co Ltd Partnership holds 344 shares. Ahl Prtnrs Llp invested 0.3% of its portfolio in Centene Corp (NYSE:CNC). Prudential Fincl holds 0.08% or 702,668 shares in its portfolio. Oregon Pub Employees Retirement Fund stated it has 0.07% of its portfolio in Centene Corp (NYSE:CNC). Nomura Holdg Inc holds 0.01% of its portfolio in Centene Corp (NYSE:CNC) for 27,232 shares. Schwab Charles Investment Management reported 0.06% of its portfolio in Centene Corp (NYSE:CNC). Jacobs Levy Equity Management holds 0.54% or 318,645 shares in its portfolio. Fulton Natl Bank Na, a Pennsylvania-based fund reported 8,227 shares. Lenox Wealth Mngmt Incorporated invested 0% of its portfolio in Centene Corp (NYSE:CNC). Us Financial Bank De reported 0.01% stake. United Fincl Advisers Ltd Liability Com accumulated 25,034 shares.

Analysts await Centene Corp (NYSE:CNC) to report earnings on February, 6. They expect $0.93 EPS, down 21.85% or $0.26 from last year’s $1.19 per share. CNC’s profit will be $160.44M for 25.04 P/E if the $0.93 EPS becomes a reality. After $1.35 actual EPS reported by Centene Corp for the previous quarter, Wall Street now forecasts -31.11% negative EPS growth.

Among 10 analysts covering Achillion Pharma (NASDAQ:ACHN), 7 have Buy rating, 0 Sell and 3 Hold. Therefore 70% are positive. Achillion Pharma had 23 analyst reports since August 13, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Wednesday, September 9 by Jefferies. The company was maintained on Thursday, August 13 by Maxim Group. The rating was downgraded by Leerink Swann on Friday, January 29 to “Market Perform”. The rating was maintained by Robert W. Baird on Monday, September 11 with “Hold”. Chardan Capital Markets maintained Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) on Friday, September 23 with “Sell” rating. The firm has “Outperform” rating given on Friday, February 26 by Robert W. Baird. As per Wednesday, August 9, the company rating was maintained by Chardan Capital Markets. Ladenburg Thalmann initiated Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) rating on Thursday, February 2. Ladenburg Thalmann has “Buy” rating and $10 target. As per Wednesday, May 4, the company rating was maintained by Leerink Swann. Chardan Capital Markets upgraded it to “Neutral” rating and $5 target in Friday, November 4 report.

Eventide Asset Management Llc decreased Dbv Technologies S A stake by 16,000 shares to 207,000 valued at $7.39 million in 2017Q2. It also reduced Loxo Oncology Inc (NASDAQ:LOXO) stake by 49,000 shares and now owns 530,000 shares. Kar Auction Svcs Inc (NYSE:KAR) was reduced too.

Investors sentiment increased to 1.33 in 2017 Q2. Its up 0.31, from 1.02 in 2017Q1. It increased, as 8 investors sold ACHN shares while 37 reduced holdings. 21 funds opened positions while 39 raised stakes. 101.03 million shares or 4.27% more from 96.89 million shares in 2017Q1 were reported. Bvf Il owns 3.49M shares or 2.49% of their US portfolio. Bogle Inv Mngmt LP De reported 0.09% stake. Los Angeles Cap And Equity Research holds 0% or 130,000 shares. Pacad Inv Limited invested 0.02% of its portfolio in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN). Airain Limited owns 11,640 shares. Cambridge Invest Advsrs holds 0% of its portfolio in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) for 23,130 shares. Morgan Stanley invested in 0% or 299,976 shares. American Gp Inc has invested 0% in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN). Swiss Bancorporation reported 159,400 shares stake. Moreover, Senzar Asset Mgmt Lc has 1.22% invested in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) for 1.08 million shares. Rhenman And Partners Asset Management owns 0.11% invested in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) for 166,000 shares. Connor Clark Lunn Investment Mngmt has 0.01% invested in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) for 342,549 shares. Tudor Investment Et Al stated it has 66,703 shares. Paloma Ptnrs Mngmt Com reported 13,200 shares stake. City Holdings Communication invested in 275 shares or 0% of the stock.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>